GENEKAL INDEX 



831 



Pregnancy, as cause of diabetes insipi- 

 dus, iv, 866. 



calcium and phosphate balance dur- 

 ing, iv, 757. 



calcium in blood during, iii, 322. 



creatin excretion in, iii, 176. 



defective, changes in ovaries inci- 

 dent to, ii, 607. 



eclampsia of, placenta as a factor 

 in, ii, 656. 



effect of, on hypophyseal cells, i, 



715. 

 on results of parathyroidectomy, 



i, 527. 



energy metabolism of, iii, 621. 

 before and after parturition, iii, 



634. 



comparison of, in pregnant and 



non-pregnant women, table, iii, 625. 



fetus and mammary growth during, 

 ii, 645. 



influence of, on hypophysis cerebri, 

 i, 795. 



mammary hyperplasia of, ii, 645. 



normal table of, iv, 844. 



pathological, iv, 835. 



blood examination by modern 



methods, iv, 848. 



changes of urea nitrogen in 



blood, iv, 854. 



cholesterol content of blood, iv, 



858. 



creatin in blood, iv, 855. 



creatinin in blood, iv, 855. 



eclampsia, and albuminuria, iv, 



835. 



and liver involvement, iv, 



838. 



and theories of cause of, iv, 



836. 



tables of, iv, 844, 845, 



851. 



examination of urine by mod- 

 ern methods, iv, 839. 



glycosuria, iv, 857. 



hepatic toxemia, table, iv, 853. 



historical, iv, 835. 



nitrogen in the blood, iv, 851. 



nitrogen partition in, iv, 839. 



pancreatic insufficiency, iv, 



858. 



summary of, iv, 858. 



uric acid nitrogen in blood, in- 

 crease of, iv, 857. 



urine in, further studies of, iv, 



843. 



urine in experimental liver 

 necrosis, iv, 842. 



Pregnancy, mammary hyperplasia of, 

 pathological, urobilinogen or urobi- 

 lin in urine, iv, 858. 



nausea and vomiting of, ovarian 

 therapy in, i, 157. 



placenta as a factor in uterine 

 changes of, ii, 656. 



response of suprarenals in, ii, 

 121. 



tetany associated with, i, 650, 684. 



prognosis of, i, 671. 

 Prepubertal ovary, and its role in de- 

 termining the secondary sex charac- 

 ters, ii, 573. 



Pressor response to epinephrin, factors 



modifying, ii, 230. 

 Pressure, in lymph production and 



edema, diffusion, iv, 183. 



of the solute, iv, 184. 



of the solvent, iv, 184. 



electrostatic, iv, 187. 



hydrostatic, iv, 181. 



osmotic, iv, 184. 



Pressure atrophy of the thyroid gland, 

 i, 283. 



Pressure symptoms, of goiter, i, 318. 



Priestley (1733-1804), discovery of oxy- 

 gen by, iii, 16. 



Pro-antithrombin as hepatic internal 

 secretion, ii, 681. 



Pro-estrum, ii, 551. 



Pro-estrus, ii, 581. 



Progerio, as a manifestation of in- 

 fantilism, ii, 878. 



Progressive muscular atrophy, iv, 730. 



metabolism in, iv, 730. 

 Progressive muscular dystrophy, alka- 



losis in, iv, 724. 



with creatinuria, iv, 724. 



with hypoglycemia, iv, 724. 



as an endocrin disease, iv, 728. 



blood sugar in, iv, 721. 



creatinuria in, iv, 723. 



with alkalosis, iv, 724. 



glucose administered intravenously 

 in, iv, 722. 



hypocholesterinemia in, iv, 724. 



delayed glucose utilization, iv, 

 725. 



fatty infiltration, iv, 726. 



hypoglycemia in, iv, 720. 



with alkalosis, iv, 724. 



metabolism in, carbohydrate, iv, 

 720. 



alkalosis, iv, 724. 



creatinuria, iv, 723. 



hypocholesterinemia, iv, 724. 



hypoglycemia, iv, 720. 



